论文部分内容阅读
目的:为了研究妇产血净在药流方面的临床应用,同时为了使药流的安全性更高,进而使患者的生存质量以及生育要求都有所提高。方法:对照组仅适用传统药流药物米非司酮与米索前列醇,实验组在对照组的基础上加用妇产血净,并观察记录两组患者阴道出血时间及出血量,建立正常月经周期的时间等,将这些数据进行整理并分析后得出了结论。结果:实验组的患者无论是阴道流血时间、流血量以及建立正常月经周期的时间都要优于对照组,进行统计分析后认为有统计学意义。结论:患者在进行药物流产时再予以妇产血净,可以起到减少阴道流血量、缩短出血时间,并且能够迅速建立正常的月经周期,才能有效的减少盆腔的脏器被感染的可能性,进而对患者的生存质量及生育要求有所提高,因此有推广临床广泛使用的必要。
Objective: In order to study the clinical application of maternal and fetal blood in the aspect of medical abortion, in order to make the safety of medical abortion higher, the quality of life and fertility of patients are improved. Methods: The control group only applied mifepristone and misoprostol. The experimental group was given the net maternal blood supply on the basis of the control group, and the vaginal bleeding time and bleeding volume were recorded and the normal menstruation was established Cycle time, these data are collated and analyzed to draw a conclusion. Results: Patients in the experimental group had better vaginal bleeding time, blood loss, and normal menstrual cycle time than those in the control group. Statistical analysis was considered statistically significant. Conclusions: The patient should be given maternal blood net when performing medical abortion, which can reduce the amount of vaginal bleeding, shorten the bleeding time, and quickly establish a normal menstrual cycle, in order to effectively reduce the pelvic organ infection possibility, In turn, the patient’s quality of life and reproductive requirements have increased, it is necessary to promote the widespread use of clinical.